PEAK6 Investments’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-13,100
Closed -$2.71M 3585
2024
Q2
$2.71M Sell
13,100
-14,400
-52% -$3.26M 0.01% 1177
2024
Q1
$7.45M Buy
27,500
+24,200
+733% +$5.78M 0.02% 638
2023
Q4
$780K Sell
3,300
-7,500
-69% -$1.47M ﹤0.01% 2291
2023
Q3
$2.12M Buy
+10,800
New +$2.22M 0.01% 1290
2023
Q2
Sell
-1,600
Closed -$323K 4027
2023
Q1
$323K Buy
1,600
+1,200
+300% +$272K ﹤0.01% 2749
2022
Q4
$87.2K Sell
400
-5,900
-94% -$1.29M ﹤0.01% 3726
2022
Q3
$1.24M Buy
6,300
+300
+5% +$64.8K 0.01% 1986
2022
Q2
$1.28M Sell
6,000
-3,400
-36% -$831K ﹤0.01% 2812
2022
Q1
$2.67M Sell
9,400
-30,600
-77% -$9.44M 0.01% 1616
2021
Q4
$15.1M Sell
40,000
-11,900
-23% -$4.62M 0.03% 530
2021
Q3
$21.4M Buy
51,900
+22,800
+78% +$9.47M 0.05% 362
2021
Q2
$10.8M Sell
29,100
-12,600
-30% -$4.21M 0.03% 643
2021
Q1
$12.1M Buy
41,700
+31,300
+301% +$8.7M 0.03% 541
2020
Q4
$2.6M Sell
10,400
-11,400
-52% -$2.72M 0.01% 1629
2020
Q3
$4.94M Sell
21,800
-8,800
-29% -$1.83M 0.01% 960
2020
Q2
$5.33M Buy
30,600
+28,500
+1,357% +$4.55M 0.02% 784
2020
Q1
$265K Buy
+2,100
New +$315K ﹤0.01% 2605
2019
Q4
Sell
-3,000
Closed -$397K 3487
2019
Q3
$397K Buy
3,000
+1,900
+173% +$255K ﹤0.01% 2441
2019
Q2
$156K Sell
1,100
-11,100
-91% -$1.51M ﹤0.01% 2980
2019
Q1
$1.77M Buy
12,200
+10,200
+510% +$1.34M 0.01% 1390
2018
Q4
$226K Sell
2,000
-21,300
-91% -$2.67M ﹤0.01% 2942
2018
Q3
$3.13M Buy
+23,300
New +$2.88M 0.01% 1100

Other funds holding CRL